Based on machine learning, CDC20 has been identified as a biomarker for postoperative recurrence and progression in stage I

Overview of attention for article published in Frontiers in oncology, July 2024

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 1 Mendeley

So far, Altmetric has seen 1 X post from an account with 6,544 followers.

New Research: Based on machine learning, CDC20 has been identified as a biomarker for postoperative recurrence and progression in stage I & II lung adenocarcinoma patients https://t.co/MhMAdqbUIA #FrontiersIn #Oncology

24 Jul 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.